Vor Biopharma Inc.

NASDAQ:VOR

Biotechnology

Healthcare
$18.52 -2.26%

-$0.34 today

Market cap
$1.00B
Beta
1.73
P/E (TTM)
-0.0
EPS (TTM)
-$2,053.13
52W Low $4.28High $65.80

Volume 0.83M

Average 1.07M

Returns on capital

Vor Biopharma Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

423.6%

avg -1.8%

ROIC

-84.6%

avg -47.7%

ROA

-150.0%

avg -115.9%

Analysis

ROE is currently the strongest return metric at 423.6% versus its period average of -1.8%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Robert Ang MBBS

Strategic AdvisorUSD 2M52——

Jean-Paul Kress

Chairman, President & CEOUSD 1.01M610<0.01%

Jeremy Sokolove

Chief Medical OfficerUSD 695.16K52——

Sandesh Mahatme

Chief Business Officer & Chief Financial OfficerUSD 603.81K610<0.01%

Navid Z. Khan

Chief Medical Affairs Officer————

Siddhartha Mukherjee DPHIL

Scientific Founder & Chairman of Scientific Advisory Board—55——

Adi Osovsky

General Counsel————

Carol Lincoln

Head of Human Resources————

Dallan Murray

Chief Commercial Officer—56——

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Dec 5, 2025.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

16

$49.42M

Net Transaction Value

−$49.42M

Net selling

Most Active

RA CAPITAL MANAGEMENT, L.P.

16 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Jul 16, 26

RA CAPITAL MANAGEMENT, L.P.

Indirect

Sell$4.2K
Apr 22, 26

RA CAPITAL MANAGEMENT, L.P.

Indirect

Sell$2.6M
Apr 20, 26

RA CAPITAL MANAGEMENT, L.P.

Indirect

Sell$2.7M
Apr 17, 26

RA CAPITAL MANAGEMENT, L.P.

Indirect

Sell$7.5M
Apr 15, 26

RA CAPITAL MANAGEMENT, L.P.

Indirect

Sell$858.8K
Apr 14, 26

RA CAPITAL MANAGEMENT, L.P.

Indirect

Sell$2.5M
Apr 13, 26

RA CAPITAL MANAGEMENT, L.P.

Indirect

Sell$8.6M
Apr 10, 26

RA CAPITAL MANAGEMENT, L.P.

Indirect

Sell$13K
Apr 9, 26

RA CAPITAL MANAGEMENT, L.P.

Indirect

Sell$2.2M
Apr 8, 26

RA CAPITAL MANAGEMENT, L.P.

Indirect

Sell$5.8M

1–10 of 16

Summary

Insiders reported 0 buys worth $0.00 and 16 sells worth $49.42M over the last 12 months. That adds up to net selling of $49.42M. RA CAPITAL MANAGEMENT, L.P. was the most active insider with 16 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A6 analysts
RevenueN/AN/AN/A
N/A7 analysts
Net IncomeN/AN/AN/A
N/A7 analysts
EBITN/AN/AN/A
N/A7 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Vor Biopharma Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about VOR's management, answered from reported figures.

Who manages VOR?

Vor Biopharma Inc. (VOR) lists 9 active executives. The top listed executive is Jeremy Sokolove, Chief Medical Officer.

Are VOR insiders buying or selling?

Recent insider activity shows net selling of $100.06M.